Form 4 for HCWB HCW Biologics Inc.
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-07 · accession 0000950170-25-068292 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-09 | 2025-05-08 | HCWB | Wong Hing C | CEO, Dir, 10% | P - Purchase | $26.00 | +92.5K | 493.9K | +23% | +$2.40M |
| D | 2025-05-09 | 2025-05-07 | HCWB | Wong Hing C | CEO, Dir, 10% | P - Purchase | $0.00 | +46.2K | 46.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-08 | P | A | 92,500 | $26.00 | 493,857 | D | — | — | |
| 2 | Derivative | Common Stock Purchase Warrant | 2025-05-07 | P | A | 46,250 | $0.00 | 46,250 | D | $26.00 · 2025-05-07 to 2030-05-07 | 46,250 Common Stock |